{"Based on the genotype result, this patient is predicted to be a CYP2C19 poor metabolizer. Avoid clopidogrel if possible due to the risk of therapeutic failure. Use an alternative antiplatelet agent at standard dose if no contraindication. Prasugrel is contraindicated in patients with a history of transient ischemic attack or stroke. Please consult a clinical pharmacist for more information."}